SCHEMBL7869991

SCHEMBL7869991

FC(Cc1ccccc1)CC1CCN(Cc2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 1/20 0.59
ACHE P22303 1/20 0.53
ALDH1A1 P00352 1/20 0.52
CXCR4 P61073 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863136 0.82 CCR3 (0.59) CCR3ACHEALDH1A1CXCR4
SCHEMBL8245441 0.80 ACHE (0.67) CCR3ACHEALDH1A1CXCR4
SCHEMBL7683729 0.78 CCR3 (0.55) CCR3ACHECXCR4
SCHEMBL4505448 0.77 CCR3 (0.61) CCR3ACHEALDH1A1CXCR4
SCHEMBL7687976 0.77 CCR3 (0.61) CCR3ACHECXCR4
SCHEMBL7871223 0.76 GBA1 (0.56)
Ammonia Solution, Strong SCHEMBL5193525 0.76 CCR3 (0.59) CCR3ACHEALDH1A1CXCR4
Hydrochloric Acid SCHEMBL7683518 0.76 BCHE (0.60) CCR3ACHECXCR4
SCHEMBL20214251 0.76 CCR3 (0.59) CCR3ACHEALDH1A1CXCR4
SCHEMBL15140944 0.75 CCR3 (0.73) CCR3ACHEALDH1A1CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed